Latest Breaking News On - Suneel gupta - Page 1 : comparemela.com

Healthcare leaders are 'strangled by time'

Healthcare leaders are 'strangled by time'
healthcarefinancenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcarefinancenews.com Daily Mail and Mail on Sunday newspapers.

Suneel-gupta
Susan-morse
Executive-summit

Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Expectations By $0.39 EPS

Protagonist Therapeutics (NASDAQ:PTGX) Releases Quarterly Earnings Results, Beats Expectations By $0.39 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Blackrock
United-kingdom-general
United-kingdom
Suneel-gupta
Protagonist-therapeutics-company-profile
Blackrock-inc
Jpmorgan-chase-co
Protagonist-therapeutics-inc
Perceptive-advisors
Nasdaq
Protagonist-therapeutics
Get-free-report

Protagonist Therapeutics (NASDAQ:PTGX) Releases Earnings Results, Beats Expectations By $0.39 EPS

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.39, MarketWatch Earnings reports. The business had revenue of $60.00 million during the quarter, compared to the consensus estimate of $60.00 million. Protagonist Therapeutics […]

Suneel-gupta
Tower-research-capital
Jpmorgan-chase-co
Protagonist-therapeutics-inc
Ensign-peak-advisors-inc
Protagonist-therapeutics-company-profile
Protagonist-therapeutics
Get-free-report
Marketwatch-earnings
Research-capital
Street-group
Peak-advisors-inc

Connor Clark & Lunn Investment Management Ltd. Sells 23,931 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Connor Clark & Lunn Investment Management Ltd. trimmed its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 139,494 shares of the company’s stock after selling 23,931 shares during the […]

Suneel-gupta
Algert-global
Exchange-commission
Jpmorgan-chase-co
Protagonist-therapeutics-company-profile
Hermes-inc
Healthcare-of-ontario-pension-plan-trust-fund
Northern-trust-corp
Connor-clark-lunn-investment-management-ltd
Nasdaq
Protagonist-therapeutics-inc
Connor-clark

Connor Clark & Lunn Investment Management Ltd. Sells 23,931 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)

Connor Clark & Lunn Investment Management Ltd. trimmed its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 139,494 shares of the company’s stock after selling 23,931 shares during the […]

Suneel-gupta
Protagonist-therapeutics-inc
Nasdaq
Connor-clark-lunn-investment-management-ltd
Northern-trust-corp
Hermes-inc
Healthcare-of-ontario-pension-plan-trust-fund
Protagonist-therapeutics-company-profile
Jpmorgan-chase-co
Algert-global
Exchange-commission
Connor-clark